| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Khan Imran | Director | C/O DAVE INC., 1265 S. COCHRAN AVENUE, LOS ANGELES | /s/ Joan Aristei as Attorney-in-Fact for Imran Khan | 19 Dec 2025 | 0001699292 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DAVE | Class A Common Stock | Sale | $49,763 | -246 | -21% | $202.29 | 900 | 18 Dec 2025 | By Proem Special Situations Fund I, LP | F1, F2 |
| transaction | DAVE | Class A Common Stock | Sale | $101,950 | -500 | -56% | $203.90 | 400 | 18 Dec 2025 | By Proem Special Situations Fund I, LP | F1, F3 |
| transaction | DAVE | Class A Common Stock | Sale | $61,060 | -298 | -74% | $204.90 | 102 | 18 Dec 2025 | By Proem Special Situations Fund I, LP | F1, F4 |
| transaction | DAVE | Class A Common Stock | Sale | $21,005 | -102 | -100% | $205.93 | 0 | 18 Dec 2025 | By Proem Special Situations Fund I, LP | F1, F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on behalf of Proem Special Situations Fund I, LP on March 14, 2025. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.95 to $202.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.18 to $204.12, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.49 to $205.48, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.52 to $206.10, inclusive. |
Due to the limitation on the number of transactions that can be reported on a single Form 4, this Form 4 is the second of two being filed by the Reporting Person on the date hereof.